Main Article Content
Abstract
According to epidemiological studies in the Russian Federation, the prevalence of overweight in different regions ranges from 5.5 % to 11.8 %, and obesity affects more than 5.5 % of children living in rural areas and 8.5 % of urban children.
Childhood obesity has both short-term and long-term adverse effects on physical and psychosocial health and is largely a risk factor for the development of cardiovascular diseases, diabetes, orthopedic problems and mental disorders.
The article describes the experience of doctors of pediatric endocrinologists of the Kuzbass Clinical Hospital named after S.V. Belyaev. Observations at a polyclinic consultation of 114 obese children and adolescents for 3 years showed the following: more than 99 % of children had primary (constitutional-exogenous type) obesity, adherence to treatment, i.e. long-term dieting, was observed in half of the patients, good results in weight loss were observed in adolescents of both sexes. 10 % of children had complications: a) disorders of carbohydrate metabolism in the form of impaired carbohydrate tolerance, impaired fasting glycemia; b) fat metabolism in the form of hypertriglyceridemia, dyslipidemia; c) increased atherogenicity, fatty hepatosis; transient increase in blood pressure, flat feet and scoliosis, osteopenia. 10 % of patients had a violation of reproductive function-multifollicular ovaries, menstrual disorders; in 9 % of boys, the rate of puberty was delayed. In 20 % of children morbid obesity increased. Metabolic disorders in the form of hyperinsulinemia and insulin resistance appear in children already in preschool age.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Federal clinical guidelines (protocols) for the management of children with endocrine diseases /ed. by II Dedov, VA Peterkova. M.: Praktika, 2014. 442 p. Russian (Федеральные клинические рекомендации (протоколы) по ведению детей с эндокринными заболеваниями /под ред. И.И. Дедова, В.А. Петерковой. М.: Практика, 2014. 442 с.)
WHO. Ожирение и избыточный вес. Режим доступа: http://www.who.int/mediacentre/factsheets/fs311/ru/
Vasyukova OV. Obesity in children and adolescents: diagnosis criteria. Obesity and Metabolism. 2019; 16(1): 70-73. Russian (Васюкова О.В. Ожирение у детей и подростков: критерии диагноза //Ожирение и метаболизм. 2019. Т. 16, № 1. С. 70-73)
Latest data shows southern European countries have highest rate of childhood obesity. Available at: https://www.euro.who.int/en/health-topics/disease-prevention/physical-activity/news/news/2018/5/latest-data-shows-southern-european-countries-have-highest-rate-of-childhood-obesity
Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH, et al. Pediatric obesity - assessment, treatment, and prevention: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 2017; 102(3): 709-757. doi: 10.1210/jc.2016-2573
Ushakova GA, Elgina SI. Methodology and organization of prevention of violations of the formation of the reproductive system of girls. Reproductive Health of Children and Adolescents. 2008; (6): 29-35. Russian (Ушакова Г.А., Елгина С.И. Методология и организация профилактики нарушений формирования репродуктивной системы девочек //Репродуктивное здоровье детей и подростков. 2008. № 6. С. 29-35)
Nikolaeva LB, Ushakova GA, Elgina SI. Forecast of population reproduction and reproductive health of Kuzbass girls. Mother and Baby in Kuzbass. 2010; (1): 19-27. Russian (Николаева Л.Б., Ушакова Г.А. Елгина С.И. Прогноз воспроизводства населения и репродуктивное здоровье девочек Кузбасса //Мать и Дитя в Кузбассе. 2010. № 1. С. 19-27)
Mead E, Atkinson G, Richter B, Metzendorf MI, Baur L, Finer N, et al. Drug interventions for the treatment of obesity in children and adolescents. Cochrane Database Syst Rev. 2016; 11(11): CD012436. doi: 10.1002/14651858.CD012436
Kelly AS, Auerbach P, Barrientos-Perez M, Gies I, Hale PM, Marcus C, et al. A randomized, controlled trial of liraglutide for adolescents with obesity. N Engl J Med. 2020; 382(22): 2117-2128. doi: 10.1056/NEJMoa1916038
Mastrandrea LD, Witten L, Carlsson Petri KCC, Hale PM, Hedman HK, Riesenberg RA. Liraglutide effects in a paediatric (7-11 y) population with obesity: a randomized, double-blind, placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics. Pediatr Obes. 2019; 14(5): e12495. doi: 10.1111/ijpo.12495
Mayer-Davis EJ, Kahkoska AR, Jefferies C, Dabelea D, Balde N, Gong CX, et al. ISPAD Clinical Practice Consensus Guidelines 2018: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2018; 19(suppl. 27): 7-19. doi: 10.1111/pedi.12773
Classification and diagnosis of diabetes: standards of Medical Care in Diabetes 2020. Diabetes Care. 2020; 43(Suppl. 1): S14-S31. doi: 10.2337/dc20-S002